Cost-effectiveness of adjuvant systemic therapy in low-risk breast cancer patients with nodal isolated tumor cells or micrometastases

M. de Boer, E. M. M. Adang, K. C. G. Van Dycke, J. A. A. M. van Dijck, G. F. Borm, S. C. Seferina, C. H. M. van Deurzen, P. J. van Diest, P. Bult, A. R. T. Donders, V. C. G. Tjan-Heijnen

Research output: Contribution to journalArticleAcademicpeer-review

2 Citations (Scopus)
Original languageEnglish
Pages (from-to)2585-2591
JournalAnnals of Oncology
Volume23
Issue number10
DOIs
Publication statusPublished - Oct 2012

Keywords

  • adjuvant systemic therapy
  • breast cancer
  • cost-effectiveness
  • isolated tumor cells
  • micrometastases

Cite this

de Boer, M., Adang, E. M. M., Van Dycke, K. C. G., van Dijck, J. A. A. M., Borm, G. F., Seferina, S. C., van Deurzen, C. H. M., van Diest, P. J., Bult, P., Donders, A. R. T., & Tjan-Heijnen, V. C. G. (2012). Cost-effectiveness of adjuvant systemic therapy in low-risk breast cancer patients with nodal isolated tumor cells or micrometastases. Annals of Oncology, 23(10), 2585-2591. https://doi.org/10.1093/annonc/mds051